Cerulean Pharma's IPO

Cerulean Pharma raised a round of funding on April 10, 2014. Investors include Public.

Cerulean Pharma, formerly Tempo Pharamaceuticals, is a clinical-stage company specializing in the development of dynamically tumor-targeted nanopharmaceuticals. Cerulean is applying its nanopharmaceut…

Articles about Cerulean Pharma's IPO: